Clinical Trial Update: Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy combined with a PD-1 inhibitor and GM-CSF for advanced recurrent metastatic head and neck tumors; current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• PD-1 inhibitor

Snippet

Sponsor: Xiangpan Li | Conditions: Objective Response Rate | Phase 2 | Status: UNKNOWN